CR2002X: A Randomised, Double Blind Phase 2 Trial of 3 Marimastat Treatment Regimens for Colorectal Cancer

  • Kerr, David (Principal Investigator)

Project Details

Short titleCR2002X: A Randomised, Double Blind Phase 2 Trial of 3 Marimastat Treatment Regimens for Colorectal Cancer
StatusFinished
Effective start/end date1/12/9930/11/01

Funding

  • BRITISH BIOTECH PHARMACEUTICALS LTD